Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation.

Atzema CL, Jackevicius CA, Chong A, Dorian P, Ivers NM, Parkash R, Austin PC.

CMAJ. 2019 Dec 9;191(49):E1345-E1354. doi: 10.1503/cmaj.190747.

2.

Population Impact of Generic Valsartan Recall.

Jackevicius CA, Krumholz HM, Chong A, Koh M, Ozaki AF, Austin PC, Udell JA, Ko DT.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044494. [Epub ahead of print]

PMID:
31707798
3.

Evaluation of Patients with Heart Failure to Determine Eligibility for Treatment with Sacubitril/Valsartan: Insights from a Veterans Administration Healthcare System.

Han J, Chung F, Nguyen QL, Mody FV, Jackevicius CA.

Pharmacotherapy. 2019 Nov;39(11):1053-1059. doi: 10.1002/phar.2328. Epub 2019 Oct 10.

PMID:
31498903
4.

Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials.

Sparrow RT, Khan AM, Ferreira-Legere LE, Ko DT, Jackevicius CA, Goodman SG, Anderson TJ, Stacey D, Tiszovszky I, Farkouh ME, Tu JV, Udell JA.

JAMA Cardiol. 2019 Aug 28. doi: 10.1001/jamacardio.2019.3066. [Epub ahead of print]

PMID:
31461127
5.

Cross-cultural Comparison of Pharmacy Students' Attitudes, Knowledge, Practice, and Barriers Regarding Evidence-based Medicine.

Ozaki AF, Nakagawa S, Jackevicius CA.

Am J Pharm Educ. 2019 Jun;83(5):6710. doi: 10.5688/ajpe6710.

6.

Long-Term Vitamin K Antagonists and Cancer Risk: A Systematic Review and Meta-Analysis.

Shurrab M, Quinn KL, Kitchlu A, Jackevicius CA, Ko DT.

Am J Clin Oncol. 2019 Sep;42(9):717-724. doi: 10.1097/COC.0000000000000571.

PMID:
31313676
7.

Submissions from the SPRINT Data Analysis Challenge on clinical risk prediction: a cross-sectional evaluation.

Jackevicius CA, An J, Ko DT, Ross JS, Angraal S, Wallach JD, Koh M, Song J, Krumholz HM.

BMJ Open. 2019 Mar 23;9(3):e025936. doi: 10.1136/bmjopen-2018-025936.

8.

Student pharmacists' performance and perceptions on an evidence-based medicine objective structured clinical examination.

Aranda JP, Davies ML, Jackevicius CA.

Curr Pharm Teach Learn. 2019 Mar;11(3):302-308. doi: 10.1016/j.cptl.2018.12.012. Epub 2019 Jan 4.

PMID:
30904154
9.

A Longitudinal Evidence-Based Medicine Curriculum and Its Impact on the Attitudes and Perceptions of Student Pharmacists.

Vira P, Nazer L, Phung O, Jackevicius CA.

Am J Pharm Educ. 2019 Feb;83(1):6510. doi: 10.5688/ajpe6510.

10.

Reply: Safety of Alpha-Adrenergic Receptor Antagonists in Heart Failure.

Jackevicius CA, Ghaznavi Z, Lu L, Warner AL.

JACC Heart Fail. 2019 Mar;7(3):276-277. doi: 10.1016/j.jchf.2018.12.005. No abstract available.

PMID:
30819387
11.

Key Articles and Guidelines in the Management of Heart Failure: 2018 Update.

Jackevicius CA, Page RL, Buckley LF, Jennings DL, Nappi JM, Smith AJ.

J Pharm Pract. 2019 Feb;32(1):77-92. doi: 10.1177/0897190018819413. Epub 2018 Dec 19. Review.

PMID:
30798691
12.

Medication Co-payment Vouchers, Adherence With Antiplatelet Therapy, and Adverse Cardiovascular Events After Myocardial Infarction.

Jackevicius CA, Ko DT.

JAMA. 2019 Jan 1;321(1):37-39. doi: 10.1001/jama.2018.20396. No abstract available.

PMID:
30620355
13.

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study.

Ko DT, Khan AM, Kotrri G, Austin PC, Wijeysundera HC, Koh M, Chu A, Jackevicius CA, Lawler PR, Tu JV.

J Am Heart Assoc. 2018 Nov 6;7(21):e010007. doi: 10.1161/JAHA.118.010007.

14.

Effect of early physician follow-up on mortality and subsequent hospital admissions after emergency care for heart failure: a retrospective cohort study.

Atzema CL, Austin PC, Yu B, Schull MJ, Jackevicius CA, Ivers NM, Rochon PA, Lee DS.

CMAJ. 2018 Dec 17;190(50):E1468-E1477. doi: 10.1503/cmaj.180786.

15.

Factors associated with door-in to door-out delays among ST-segment elevation myocardial infarction (STEMI) patients transferred for primary percutaneous coronary intervention: a population-based cohort study in Ontario, Canada.

Shi O, Khan AM, Rezai MR, Jackevicius CA, Cox J, Atzema CL, Ko DT, Stukel TA, Lambert LJ, Natarajan MK, Zheng ZJ, Tu JV.

BMC Cardiovasc Disord. 2018 Oct 29;18(1):204. doi: 10.1186/s12872-018-0940-z.

16.

Safety of Alpha-Adrenergic Receptor Antagonists in Heart Failure.

Jackevicius CA, Ghaznavi Z, Lu L, Warner AL.

JACC Heart Fail. 2018 Nov;6(11):917-925. doi: 10.1016/j.jchf.2018.06.015. Epub 2018 Oct 10.

17.

Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.

Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.

JAMA Intern Med. 2018 Sep 1;178(9):1182-1189. doi: 10.1001/jamainternmed.2018.3189.

18.

Long-term risk of stroke and bleeding post-atrial fibrillation ablation.

Joza J, Samuel M, Jackevicius CA, Behlouli H, Jia J, Koh M, Tsadok MA, Tang ASL, Verma A, Pilote L, Essebag V.

J Cardiovasc Electrophysiol. 2018 Oct;29(10):1355-1362. doi: 10.1111/jce.13702. Epub 2018 Oct 12.

PMID:
30047574
19.

Population-Based Evaluation of Major Adverse Events After Catheter Ablation for Atrial Fibrillation.

Samuel M, Almohammadi M, Tsadok MA, Joza J, Jackevicius CA, Koh M, Behlouli H, Verma A, Pilote L, Essebag V.

JACC Clin Electrophysiol. 2017 Dec 11;3(12):1425-1433. doi: 10.1016/j.jacep.2017.04.010. Epub 2017 Aug 30.

20.

Projected Real-World Effectiveness of Using Aggressive Low-Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada.

Alter DA, Tu JV, Koh M, Jackevicius CA, Austin PC, Rezai MR, Bhatia RS, Johnston S, Udell JA, Ko DT.

J Am Heart Assoc. 2018 May 12;7(10). pii: e007535. doi: 10.1161/JAHA.117.007535.

21.

Stopping β-Blockers After Myocardial Infarction: Not So Fast!

Ko DT, Jackevicius CA.

Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004678. doi: 10.1161/CIRCOUTCOMES.118.004678. No abstract available.

PMID:
29654002
22.

Physician follow-up and long-term use of evidence-based medication for patients with hypertension who were discharged from an emergency department: a prospective cohort study.

Atzema CL, Yu B, Schull MJ, Jackevicius CA, Ivers NM, Lee DS, Rochon P, Austin PC.

CMAJ Open. 2018 Apr 3;6(2):E151-E161. doi: 10.9778/cmajo.20170119.

23.

Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome.

Ko DT, Krumholz HM, Tu JV, Austin PC, Stukel TA, Koh M, Chong A, de Melo JF Jr, Jackevicius CA.

Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004194. doi: 10.1161/CIRCOUTCOMES.117.004194.

PMID:
29535091
24.

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy.

Wijeysundera HC, Koh M, Alter DA, Austin PC, Jackevicius CA, Tu JV, Ko DT.

Open Heart. 2017 Dec 17;4(2):e000731. doi: 10.1136/openhrt-2017-000731. eCollection 2017.

25.

Elephant in the Room: Cost of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors.

Jackevicius CA.

Circ Cardiovasc Qual Outcomes. 2018 Jan;11(1):e004425. doi: 10.1161/CIRCOUTCOMES.117.004425. No abstract available.

PMID:
29326147
26.

Improving admission medication reconciliation with pharmacists or pharmacy technicians in the emergency department: a randomised controlled trial.

Pevnick JM, Nguyen C, Jackevicius CA, Palmer KA, Shane R, Cook-Wiens G, Rogatko A, Bear M, Rosen O, Seki D, Doyle B, Desai A, Bell DS.

BMJ Qual Saf. 2018 Jul;27(7):512-520. doi: 10.1136/bmjqs-2017-006761. Epub 2017 Oct 6.

27.

Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.

Borne RT, O'Donnell C, Turakhia MP, Varosy PD, Jackevicius CA, Marzec LN, Masoudi FA, Hess PL, Maddox TM, Ho PM.

BMC Cardiovasc Disord. 2017 Sep 2;17(1):236. doi: 10.1186/s12872-017-0671-6.

28.

Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication Adherence.

Lu L, Jackevicius CA, de Leon NK, Warner AL, Chang DS, Mody FV.

Clin Ther. 2017 Jun;39(6):1200-1209. doi: 10.1016/j.clinthera.2017.04.012. Epub 2017 May 22.

PMID:
28545803
29.

Regional variations in ambulatory care and incidence of cardiovascular events.

Tu JV, Chu A, Maclagan L, Austin PC, Johnston S, Ko DT, Cheung I, Atzema CL, Booth GL, Bhatia RS, Lee DS, Jackevicius CA, Kapral MK, Tu K, Wijeysundera HC, Alter DA, Udell JA, Manuel DG, Mondal P, Hogg W; Cardiovascular Health in Ambulatory Care Research Team (CANHEART).

CMAJ. 2017 Apr 3;189(13):E494-E501. doi: 10.1503/cmaj.160823.

30.

Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.

Jackevicius CA, Tsadok MA, Essebag V, Atzema C, Eisenberg MJ, Tu JV, Lu L, Rahme E, Ho PM, Turakhia M, Humphries KH, Behlouli H, Zhou L, Pilote L.

Heart. 2017 Sep;103(17):1331-1338. doi: 10.1136/heartjnl-2016-310672. Epub 2017 Mar 12.

PMID:
28286333
31.

High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.

Ko DT, Alter DA, Guo H, Koh M, Lau G, Austin PC, Booth GL, Hogg W, Jackevicius CA, Lee DS, Wijeysundera HC, Wilkins JT, Tu JV.

J Am Coll Cardiol. 2016 Nov 8;68(19):2073-2083. doi: 10.1016/j.jacc.2016.08.038.

32.

Access to Evidence-Based Statins in Low-Cost Generic Drug Programs.

Jackevicius CA, Choi K, Krumholz HM.

Circ Cardiovasc Qual Outcomes. 2016 Nov;9(6):785-787. doi: 10.1161/CIRCOUTCOMES.116.002985. Epub 2016 Nov 1. No abstract available.

PMID:
27803089
33.

Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial.

Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Khan NF, Lee M, Vachon A, Iliadis TL, Hollands W, Doheny S, Elman S, Kraft JM, Naseem S, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.

Am Heart J. 2016 Oct;180:90-7. doi: 10.1016/j.ahj.2016.07.017. Epub 2016 Aug 8.

34.

The impact of drug shortages on patients with cardiovascular disease: causes, consequences, and a call to action.

Reed BN, Fox ER, Konig M, Jackevicius CA, Masoudi FA, Rabinstein AA, Page RL 2nd.

Am Heart J. 2016 May;175:130-41. doi: 10.1016/j.ahj.2016.02.004. Epub 2016 Feb 16. Review.

PMID:
27179732
35.

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome.

Jackevicius CA, Tu JV, Krumholz HM, Austin PC, Ross JS, Stukel TA, Koh M, Chong A, Ko DT.

J Am Heart Assoc. 2016 Apr 19;5(4):e003350. doi: 10.1161/JAHA.116.003350.

36.

Potential benefit of electronic pharmacy claims data to prevent medication history errors and resultant inpatient order errors.

Pevnick JM, Palmer KA, Shane R, Wu CN, Bell DS, Diaz F, Cook-Wiens G, Jackevicius CA.

J Am Med Inform Assoc. 2016 Sep;23(5):942-50. doi: 10.1093/jamia/ocv171. Epub 2016 Jan 17.

37.

Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.

Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Pilote L.

Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):593-9. doi: 10.1161/CIRCOUTCOMES.114.001398. Epub 2015 Oct 27.

PMID:
26508666
38.

Dabigatran use in elderly patients with atrial fibrillation.

Avgil-Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Behlouli H, Pilote L.

Thromb Haemost. 2016 Jan;115(1):152-60. doi: 10.1160/TH15-03-0247. Epub 2015 Sep 10.

PMID:
26354766
39.

Impact of a Multidisciplinary Heart Failure Post-hospitalization Program on Heart Failure Readmission Rates.

Jackevicius CA, de Leon NK, Lu L, Chang DS, Warner AL, Mody FV.

Ann Pharmacother. 2015 Nov;49(11):1189-96. doi: 10.1177/1060028015599637. Epub 2015 Aug 10.

PMID:
26259774
40.

The Long-Term Use of Warfarin Among Atrial Fibrillation Patients Discharged From an Emergency Department With a Warfarin Prescription.

Atzema CL, Austin PC, Chong AS, Dorian P, Jackevicius CA.

Ann Emerg Med. 2015 Oct;66(4):347-354.e2. doi: 10.1016/j.annemergmed.2015.03.024. Epub 2015 May 9.

PMID:
25964082
41.

Warfarin Treatment and Outcomes of Patients With Atrial Fibrillation in Rural and Urban Settings.

Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Pilote L.

J Rural Health. 2015 Summer;31(3):310-5. doi: 10.1111/jrh.12110. Epub 2015 Feb 25.

PMID:
25716686
42.

The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services.

Tu JV, Chu A, Donovan LR, Ko DT, Booth GL, Tu K, Maclagan LC, Guo H, Austin PC, Hogg W, Kapral MK, Wijeysundera HC, Atzema CL, Gershon AS, Alter DA, Lee DS, Jackevicius CA, Bhatia RS, Udell JA, Rezai MR, Stukel TA.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):204-12. doi: 10.1161/CIRCOUTCOMES.114.001416. Epub 2015 Feb 3.

PMID:
25648464
43.

Response to letter regarding article, "Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis".

Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Guo H, Pilote L.

Circulation. 2014 Dec 23;130(25):e428-9. doi: 10.1161/CIRCULATIONAHA.114.012785. No abstract available.

PMID:
25539527
44.

Laboratory monitoring for pharmaceuticals: familiarity does not breed contempt.

Jackevicius CA, Glassman P.

J Gen Intern Med. 2014 Dec;29(12):1574-6. doi: 10.1007/s11606-014-3048-x. No abstract available.

45.
46.

Effect of electronic prescribing with formulary decision support on medication tier, copayments, and adherence.

Pevnick JM, Li N, Asch SM, Jackevicius CA, Bell DS.

BMC Med Inform Decis Mak. 2014 Aug 28;14:79. doi: 10.1186/1472-6947-14-79.

47.

Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.

Ross JS, Frazee SG, Garavaglia SB, Levin R, Novshadian H, Jackevicius CA, Stettin G, Krumholz HM.

JAMA Intern Med. 2014 Sep;174(9):1486-93. doi: 10.1001/jamainternmed.2014.3404.

48.

Predictors of erythropoietin use in patients with cardiorenal anaemia syndrome.

Jackevicius CA, Co MJ, Warner AL.

Int J Pharm Pract. 2015 Jun;23(3):199-204. doi: 10.1111/ijpp.12133. Epub 2014 Jul 2.

PMID:
24990704
49.

The pharmacist role in predicting and improving medication adherence in heart failure patients.

Davis EM, Packard KA, Jackevicius CA.

J Manag Care Spec Pharm. 2014 Jul;20(7):741-55. Review.

50.

A formal mentorship program for faculty development.

Jackevicius CA, Le J, Nazer L, Hess K, Wang J, Law AV.

Am J Pharm Educ. 2014 Jun 17;78(5):100. doi: 10.5688/ajpe785100.

Supplemental Content

Loading ...
Support Center